Gravog M 500mg/0.2mg Tablet SR
Marketer
Precise Lifescience
Salt Composition
Metformin (500mg) + Voglibose (0.2mg)
Overview Gravog M 500mg/0.2mg Tablet SR
Diabex Duo 500mg/0.2mg Extended-Release Tablets are antidiabetic medications combining two drugs to manage type 2 diabetes in adults. These tablets help regulate blood glucose. Diabex Duo should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood sugar response. Continue taking this medication even if feeling well, as discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Possible side effects include nausea, altered taste, appetite changes, gas, abdominal discomfort, diarrhea, and skin reactions. These are generally transient and resolve spontaneously. Persistent or concerning side effects warrant medical attention; your doctor can offer management strategies. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Individuals with a history of heart disease should inform their physician before use. Pregnant or breastfeeding individuals should consult their doctor prior to use. Regular blood glucose monitoring, along with potential blood tests to track blood cell counts and liver function, will be recommended by your physician.
Primary Ingredients of Gravog M 500mg/0.2mg Tablet SR
There is no text provided to rephrase.
Uses of Gravog M 500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Gravog M 500mg/0.2mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Gravog M 500mg/0.2mg Extended-Release Tablets should be administered with a meal.
Common Side effects of Gravog M 500mg/0.2mg Tablet SR:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Gravog M 500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Gravog M 500mg/0.2mg Tablet SR. Ingest the tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.
How Gravog M 500mg/0.2mg Tablet SR works:
Gravog M 500mg/0.2mg extended-release tablets contain a dual antidiabetic drug formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Gravog M 500mg/0.2mg Tablet SR with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Gravog M 500mg/0.2mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers before recommending its use. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Gravog M 500mg/0.2mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential drug transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Gravog M 500mg/0.2mg Extended-Release tablets typically do not impair driving ability. Nevertheless, patients should be aware of the potential for low blood sugar (hypoglycemia) if this medication is taken concurrently with other antidiabetic drugs including sulfonylureas, insulin, and repaglinide.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Gravog M 500mg/0.2mg sustained-release tablets. Dosage modification may be necessary; physician consultation is advised. Gravog M 500mg/0.2mg sustained-release tablets are contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Gravog M 500mg/0.2mg sustained-release tablets in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Gravog M 500mg/0.2mg Tablet SR :
Should you forget to take a Gravog M 500mg/0.2mg sustained-release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gravog M 500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently